BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22307214)

  • 1. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience.
    Korman H; Lanni T; Shah C; Parslow J; Tull J; Ghilezan M; Krauss D; Balaraman S; Kernen K; Cotant M; Margolis J; Vicini FA
    Am J Clin Oncol; 2013 Apr; 36(2):121-5. PubMed ID: 22307214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center.
    Stewart SB; BaƱez LL; Robertson CN; Freedland SJ; Polascik TJ; Xie D; Koontz BF; Vujaskovic Z; Lee WR; Armstrong AJ; Febbo PG; George DJ; Moul JW
    J Urol; 2012 Jan; 187(1):103-8. PubMed ID: 22088334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
    Magnani T; Valdagni R; Salvioni R; Villa S; Bellardita L; Donegani S; Nicolai N; Procopio G; Bedini N; Rancati T; Zaffaroni N
    BJU Int; 2012 Oct; 110(7):998-1003. PubMed ID: 22404874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Lief J; Adamovich E; Wallner KE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e225-32. PubMed ID: 21664066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer.
    Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
    Ann Thorac Surg; 2011 Oct; 92(4):1239-42; discussion 1243. PubMed ID: 21867990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with biopsy recommendations of a prostate cancer risk calculator.
    van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
    BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in quality of care for men with early-stage prostate cancer.
    Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
    J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?
    Huang J; Vicini FA; Williams SG; Ye H; McGrath S; Ghilezan M; Krauss D; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1141-8. PubMed ID: 22099043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Shariat SF; Briganti A; Abdo A; Tian Z; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1177-82. PubMed ID: 21880105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy.
    Qian Y; Feng FY; Halverson S; Blas K; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e135-42. PubMed ID: 21345617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
    Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
    BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.
    Sundi D; Cohen JE; Cole AP; Neuman BP; Cooper J; Faisal FA; Ross AE; Schaeffer EM
    Prostate; 2015 Feb; 75(2):191-9. PubMed ID: 25307625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.